Matthieu Lemasson

600 total citations
9 papers, 485 citations indexed

About

Matthieu Lemasson is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Matthieu Lemasson has authored 9 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 7 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in Matthieu Lemasson's work include Hepatitis C virus research (8 papers), Hepatitis B Virus Studies (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Matthieu Lemasson is often cited by papers focused on Hepatitis C virus research (8 papers), Hepatitis B Virus Studies (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Matthieu Lemasson collaborates with scholars based in France, Switzerland and Belgium. Matthieu Lemasson's co-authors include Roxane Lestini, Zeynep Baharoglu, Benoît Y. Michel, Hasna Boubakri, Arielle R. Rosenberg, Andrew Vaillant, Matthieu Blanchet, Patrick Labonté, Sophie Clément and Isidora Ranchal and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Matthieu Lemasson

9 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthieu Lemasson France 8 211 155 151 100 42 9 485
Anuj Kumar India 15 287 1.4× 92 0.6× 110 0.7× 45 0.5× 62 1.5× 38 553
Ahmed Atef Mesalam Egypt 14 114 0.5× 217 1.4× 195 1.3× 27 0.3× 58 1.4× 28 514
Qingjiao Liao China 11 181 0.9× 85 0.5× 135 0.9× 35 0.3× 110 2.6× 17 535
Zhikui Cheng China 12 162 0.8× 52 0.3× 104 0.7× 76 0.8× 56 1.3× 28 436
Nai-Wan Hsiao Taiwan 9 124 0.6× 186 1.2× 214 1.4× 19 0.2× 88 2.1× 10 571
Albert Théophane Yonli Burkina Faso 12 105 0.5× 81 0.5× 172 1.1× 23 0.2× 56 1.3× 68 503
Juliane Gentzsch Germany 12 119 0.6× 292 1.9× 244 1.6× 14 0.1× 51 1.2× 12 523
Annette S. Uss United States 11 202 1.0× 171 1.1× 102 0.7× 19 0.2× 100 2.4× 16 586
Véronique Pène France 11 200 0.9× 392 2.5× 308 2.0× 21 0.2× 49 1.2× 15 732
Atsuya Yamashita Japan 20 252 1.2× 264 1.7× 292 1.9× 29 0.3× 147 3.5× 52 973

Countries citing papers authored by Matthieu Lemasson

Since Specialization
Citations

This map shows the geographic impact of Matthieu Lemasson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthieu Lemasson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthieu Lemasson more than expected).

Fields of papers citing papers by Matthieu Lemasson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthieu Lemasson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthieu Lemasson. The network helps show where Matthieu Lemasson may publish in the future.

Co-authorship network of co-authors of Matthieu Lemasson

This figure shows the co-authorship network connecting the top 25 collaborators of Matthieu Lemasson. A scholar is included among the top collaborators of Matthieu Lemasson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthieu Lemasson. Matthieu Lemasson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Blanchet, Matthieu, et al.. (2020). Characterization of the antiviral effects of REP 2139 on the HBV lifecycle in vitro. Antiviral Research. 183. 104853–104853. 46 indexed citations
2.
Pène, Véronique, Matthieu Lemasson, Francis Harper, Gérard Pierron, & Arielle R. Rosenberg. (2017). Role of cleavage at the core-E1 junction of hepatitis C virus polyprotein in viral morphogenesis. PLoS ONE. 12(4). e0175810–e0175810. 2 indexed citations
3.
Benzoubir, Nassima, Sérena Battaglia, Christophe Desterke, et al.. (2017). Hepatitis C virus core protein targets 4E-BP1 expression and phosphorylation and potentiates Myc-induced liver carcinogenesis in transgenic mice. Oncotarget. 8(34). 56228–56242. 8 indexed citations
4.
Jamard, Catherine, Matthieu Lemasson, Sylviane Guérret, et al.. (2017). Nucleic acid polymer REP 2139 and nucleos(T)ide analogues act synergistically against chronic hepadnaviral infection in vivo in Pekin ducks. Hepatology. 67(6). 2127–2140. 29 indexed citations
5.
Beilstein, Frauke, Matthieu Lemasson, Véronique Pène, et al.. (2016). Lysophosphatidylcholine acyltransferase 1 is downregulated by hepatitis C virus: impact on production of lipo-viro-particles. Gut. 66(12). 2160–2169. 17 indexed citations
6.
Rojas, Ángela, J.A. Del Campo, Sophie Clément, et al.. (2016). Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host Targets. Scientific Reports. 6(1). 91 indexed citations
7.
Vausselin, Thibaut, Karin Séron, Muriel Lavie, et al.. (2016). Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus. Journal of Virology. 90(19). 8422–8434. 36 indexed citations
8.
Haid, Sibylle, Juliane Gentzsch, Dorothea Bankwitz, et al.. (2012). A Plant-Derived Flavonoid Inhibits Entry of All HCV Genotypes Into Human Hepatocytes. Gastroenterology. 143(1). 213–222.e5. 94 indexed citations
9.
Michel, Benoît Y., Hasna Boubakri, Zeynep Baharoglu, Matthieu Lemasson, & Roxane Lestini. (2007). Recombination proteins and rescue of arrested replication forks. DNA repair. 6(7). 967–980. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026